Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 12 of 12

List	Outcome	Time frame	Description
Primary	Plasma Follistatin	48 weeks	blood biomarker concentration
Primary	Plasma Myostatin	48 weeks	blood biomarker concentration
Primary	Plasma Nitrates/ SNO	48 weeks	blood biomarker concentration
Primary	Plasma BNP	48 weeks	blood biomarker concentration
Primary	Plasma Creatine Kinase	48 weeks	blood biomarker concentration
Primary	Plasma MMP-9	48 weeks	blood biomarker concentration
Primary	Plasma TNF-Alpha	48 weeks	blood biomarker concentration
Primary	Plasma TGF-Beta	48 weeks	blood biomarker concentration
Primary	Plasma Follistatin:Myostain Ratio	48 weeks	Ratio of plasma follistatin to plasma myostatin
Secondary	Graded Exercise Test Using a Recumbent Cycle Ergometer	baseline and at 2-minute intervals	blood lactate measured
Secondary	6-minute Walk Test	48 weeks	Measurements recorded will include 25-meter split times and total distance traveled.
Other	Exploratory Proteomics	48 weeks	Collection of plasma samples for proteomics analysis.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03236662/registered